Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Sun Q, Wang A, Chang H (2023) Contrast-enhanced ultrasound guidance improves the therapeutic efficacy of radiofrequency ablation in liver cancer patients. Am J Transl Res 15(6):3856–3863
2. Chhikara BS, Parang K (2023) Global cancer statistics 2022: the trends projection analysis. Chem Biol Lett 10(1):451–451
3. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77(6):1598–1606
4. Deng Q, He M, Fu C, Feng K, Ma K, Zhang L (2022) Radiofrequency ablation in the treatment of hepatocellular carcinoma. Int J Hyperthermia 39(1):1052–1063
5. Lv S, Long Y, Su Z, Zheng R, Li K, Zhou H, Qiu C, Yin T, Xu E (2019) Investigating the accuracy of ultrasound-ultrasound fusion imaging for evaluating the ablation effect via special phantom-simulated liver tumors. Ultrasound Med Biol 45(11):3067–3074